ID
13625
Description
AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00180115
Link
https://clinicaltrials.gov/show/NCT00180115
Keywords
Versions (1)
- 2/21/16 2/21/16 -
Uploaded on
February 21, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Leukemia, Nonlymphoblastic, Acute NCT00180115
Eligibility Leukemia, Nonlymphoblastic, Acute NCT00180115
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
severe comorbidities
Data type
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
complications of the leukemia
Data type
boolean
Alias
- UMLS CUI [1]
- C0544688
Description
prior therapy
Data type
boolean
Alias
- UMLS CUI [1]
- C1514463
Description
hiv
Data type
boolean
Alias
- UMLS CUI [1]
- C0019682
Description
allergy against study medication
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C1521826
Description
pregnancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
Description
missing written informed consent
Data type
boolean
Alias
- UMLS CUI [1]
- C0021430
Similar models
Eligibility Leukemia, Nonlymphoblastic, Acute NCT00180115
- StudyEvent: Eligibility
C0457321 (UMLS CUI [2])
C0457321 (UMLS CUI [2])
C1521826 (UMLS CUI [1,2])